Formula Growth’s Concentrix CNXC Stock Holding History

Formula Growth’s Portfolio CNXC Stock Details CNXC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-17,000	Closed	-$2.54M	–	155
2021 Q1	$2.54M	Buy	+17,000	New	+$2.06M	0.37%	82

Other funds holding CNXC

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

LAM

Lyrical Asset Management New York $6.56B AUM 20.06% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Formula Growth's CNXC Position: Q2 2021 in Review

Formula Growth sold out of Concentrix (CNXC) in Q2 2021, closing a stake of 17,000 shares — an estimated $2.54M sold.

Formula Growth first reported a position in CNXC in Q1 2021 and held it in 1 quarter. The position peaked at $2.54M in Q1 2021. 316 funds tracked by Wall St. Rank hold CNXC as of Q2 2021.

Formula Growth reported no remaining Concentrix position as of Q2 2021 after selling out during the quarter.
Formula Growth sold 17,000 Concentrix shares in Q2 2021, an estimated $2.54M.
Formula Growth first reported a position in Concentrix in Q1 2021 and held it in 1 quarter.
Formula Growth's Concentrix position peaked at $2.54M in Q1 2021.
316 funds tracked by Wall St. Rank held Concentrix as of Q2 2021.

Based on Formula Growth's 13F filing for Q2 2021, filed 13 Aug 2021.